Clinical trial · Observational
Studies of Dermatologic Diseases Biospecimen Acquisition Protocol
Studies of Dermatologic Diseases-Biospecimen Acquisition Protocol
- Source
- ClinicalTrials.gov
- Retrieved
- Sep 26, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-CLINICALTRIALS-20260926-000001
Summary
Brief summary (as posted)
Background: \- Skin disease can have many causes. It can have widespread consequences, and in rare cases can lead to death. Researchers want to determine the causes of various types of skin diseases and find a way to treat them. Objectives: \- To determine the causes of various skin diseases and find ways to treat them. Eligibility: * People ages 2 and older who have: * A skin disease or at risk of developing a skin disease OR * A family member of persons with a skin disease * Healthy volunteers ages 2 and older Design: * Participants will be screened under a separate protocol. * Participants may take a survey about how their skin condition affects their quality of life. * Participants will have a medical history and a physical exam including a detailed skin exam. Pictures will be taken of their skin to document any skin disease. * Participants will have specimens collected. This may include: * Several teaspoons of blood taken at each visit * Stool samples * Nail and body fluid (like saliva) samples * Cheek swabs. The inside of the cheek will be scraped for about a minute in each direction to collect cells. * Collection of skin samples with: * A swab (like a Q-tip) * Gently scraping skin to remove the outer layers of cells * Applying and removing 1-inch pieces of tape * Participants may have up to 4 skin biopsies in 12 months, with 4 separate biopsies taken each time. * An area of skin will be numbed with an injection. * A piece of skin the size of a pencil eraser will be removed using a small instrument. * A flat scar usually develops at the biopsy site.
Conditions
Conditions (4)
Free-text conditions as registered, with the CancerIndex entity they were reconciled to and the match type.
| Condition (as posted) | Mapped entity | Match | Confidence |
|---|---|---|---|
| Carcinoma, Merkel Cell | Merkel Cell Carcinoma | ALIAS | 0.90 |
| Dermatologic Conditions | — | UNRESOLVED | — |
| Healthy Volunteers | — | UNRESOLVED | — |
| Normal Volunteers | — | UNRESOLVED | — |
Interventions
Interventions (0)
Data not yet available
Design
Arms and outcomes
Arms (2)
- label
- 1/ Skin disease or at risk
- description
- Subjects with a skin disease or at risk of developing a skin disease/ Family member of persons with a skin disease
- label
- 2/ Healthy Volunteers
- description
- Healthy Volunteers
Primary outcomes (1)
- measure
- Procure biologic samples for exploratory cellular, molecular, genetic and genomic biological studies
- timeFrame
- Time of collection
- description
- Collection of biologic samples
Eligibility
Eligibility (as posted)
- Sex
- All
- Minimum age
- 1 Day
- Maximum age
- 100 Years
Show eligibility criteria text
* INCLUSION CRITERIA: * Eligible participants must: * Have a dermatologic condition, as determined by the PI or AIs, OR --be at risk for developing a dermatologic condition, as determined by the PI or AIs, OR * be a family member of a person with a dermatologic condition OR * be a healthy volunteer, as defined as a person with no known significant health problems. * Be willing to provide biospecimens for research and clinical studies, and for storage to be used for future research. * Subjects of age greater than 0 years old (including only viable neonates) are eligible. EXCLUSION CRITERIA: * Presence of conditions that, in the judgment of the investigator, may put the subject at undue risk or make them unsuitable for participation in the study. * Inability to comply with the requirements of the protocol.
References
Publications (1)
- DERIVEDAhmed N, Joglekar P, Deming C; NISC Comparative Sequencing Program; Lemon KP, Kong HH, Segre JA, Conlan S. Genomic characterization of the C. tuberculostearicum species complex, a prominent member of the human skin microbiome. mSystems. 2023 Dec 21;8(6):e0063223. doi: 10.1128/msystems.00632-23. Epub 2023 Nov 10. PMID 38126779